Ouster of Peter Marks leaves biotech sector bracing for disruptions

The latest stories trending on MedCity News.

Editor's Pick

Top Story Ouster of Peter Marks & Mass FDA Layoffs Have Biotech Sector Bracing for Regulatory Disruptions As the FDA's top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency's ability to review and potentially approve such treatments. Sponsored How PDPM Optimization Improves Facility Financial Performance Presented by Medrina Transitioning to PDPM models significantly shifted the healthcare industry. By replacing the RUG system, healthcare providers cut waste and more accurately reflect the care each patient received.  Learn More Shawn Gremminger, President & CEO of the National Alliance of Healthcare Purchaser Coalitions will be Moderating at INVEST 2025! Shawn will be part of the panel, "How are Payers and Employers Covering the Cost of GLP-1s?".  GLP-1s have proved to be highly effective weight loss drugs and have benefits tied to hypertension as well. But these expensive drugs are proving to be a headache for self-insured employers and payers. Learn from a panel of experts the various strategies that these stakeholders are employing to offer the benefit without breaking the bank. Register For INVEST Chicago Now

Featured News

The Go-To Law Firms For Healthcare and Life Sciences A look at some of the top law firms that serve companies in the healthcare and life sciences fields, from early stage startups to growth stage businesses. Venteur Raises $20M To Help Employers Administer ICHRAs Venteur's $20 million funding round was led by Informed Ventures and American Family Ventures. In total, the company has raised $30 million. SonderMind Scales Its Mental Health Services Nationwide Mental health care provider SonderMind expanded its reach from 15 to all 50 states. The company's platform combines therapy, psychiatry, and digital self-care tools. The Hidden Cracks in Healthcare's Cybersecurity Ecosystem Cybersecurity and data protection in healthcare is only as strong as its weakest crack. Medical device makers, pharmaceutical firms, health IT, privacy equity, research organizations, and consolidated systems all play a role in vulnerabilities, and their shortcomings can ripple outward, endangering patient data and trust. How Health Plans Are Adding Up Real Value From AI AI tools can work together across the payer value chain, exchanging information, collaborating and making autonomous decisions based on business rules. Here are just a few examples of how their bottom lines are benefiting.

Video   How Often Does NIH Research Lead to New Drugs and Commercialized Tech? The Trump administration is eliminating about $4 billion in NIH funding. When reporting on the impact of this change, Assistant Editor Katie Adams examined the success of NIH-funded research — how often does this research lead to new drugs or commercialized technologies?

Sponsored Top-Rated Practice Management Solutions for Med Spas Presented by PatientNow Every wellness clinic is only as successful as the capabilities of its software. Here's where you can find the top-rated practice management solutions for med spas. Learn More

Resources

MedCity FemFwd: The Link Between Intimate Partner Violence and Health In this episode, we're joined by Dr. Audrey Jiricko, senior medical director of women's health at Intermountain Health. She discusses how the organization is screening women for intimate partner violence. Watch Now!

MedCity News • PO Box 901 • New York, NY unsubscribe